Versican Plus BbPi IN Nasal Drops, Lyophilisate and Solvent for Suspension for Dogs
Versican Plus BbPi IN Nasal Drops, Lyophilisate and Solvent for Suspension for Dogs
Awtorizzat
- Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
- Bordetella bronchiseptica, strain MSLB 3096, Live
Identifikazzjoni tal-prodott
Isem tal-mediċina:
Versican Plus BbPI IN nasal drops, lyophilisate and solvent for suspension for dogs
Versican Plus BbPi IN Nasal Drops, Lyophilisate and Solvent for Suspension for Dogs
Metodu ta’ amministrazzjoni:
-
Użu għall-imnieħer
Dettalji tal-prodott
Withdrawal period by route of administration:
-
Użu għall-imnieħer
-
Dog
-
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
- QI07AF01
Status tal-awtorizzazzjoni:
-
Valid
Authorised in:
Available in:
-
United Kingdom (Northern Ireland)
Tagħrif addizzjonali
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
- Zoetis Belgium S.A.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
- Bioveta a.s.
Awtorità responsabbli:
- The Veterinary Medicines Directorate
Numru tal-awtorizzazzjoni:
- Vm 60021/3049
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
- DE/V/0288/001
Stati Membri Kkonċernati:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Dokumenti
Combined File of all Documents
Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
English (PDF)
Ippubblikat fuq: 14/11/2025
2613944-paren-20251101.pdf
English (PDF)
Niżżel Ippubblikat fuq: 27/11/2025
Kemm kienet utli din il-paġna?: